RU2005129049A - RECOMBINANT STRAINS OF INFLUENZA VIRUS EXPRESSING MYCOBACTERIAL PROTECTIVE ANTIGEN ESAT-6, AND THEIR USE FOR PREVENTION AND TREATMENT OF TUBERCULOSIS - Google Patents
RECOMBINANT STRAINS OF INFLUENZA VIRUS EXPRESSING MYCOBACTERIAL PROTECTIVE ANTIGEN ESAT-6, AND THEIR USE FOR PREVENTION AND TREATMENT OF TUBERCULOSIS Download PDFInfo
- Publication number
- RU2005129049A RU2005129049A RU2005129049/13A RU2005129049A RU2005129049A RU 2005129049 A RU2005129049 A RU 2005129049A RU 2005129049/13 A RU2005129049/13 A RU 2005129049/13A RU 2005129049 A RU2005129049 A RU 2005129049A RU 2005129049 A RU2005129049 A RU 2005129049A
- Authority
- RU
- Russia
- Prior art keywords
- tuberculosis
- influenza virus
- esat6
- influenza
- treatment
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2005129049/13A RU2318872C2 (en) | 2005-09-16 | 2005-09-16 | Recombinant influenza virus strains expressing mycobacterial protective esat-6 antigen and uses thereof in tuberculosis treatment and prophylaxis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2005129049/13A RU2318872C2 (en) | 2005-09-16 | 2005-09-16 | Recombinant influenza virus strains expressing mycobacterial protective esat-6 antigen and uses thereof in tuberculosis treatment and prophylaxis |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2005129049A true RU2005129049A (en) | 2007-03-27 |
RU2318872C2 RU2318872C2 (en) | 2008-03-10 |
Family
ID=37998854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005129049/13A RU2318872C2 (en) | 2005-09-16 | 2005-09-16 | Recombinant influenza virus strains expressing mycobacterial protective esat-6 antigen and uses thereof in tuberculosis treatment and prophylaxis |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2318872C2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2335177B1 (en) * | 2008-09-19 | 2011-02-28 | Archivel Farma, S.L. | PROPER IMMUNOTHERAPEUTIC AGENT FOR THE PRIMARY PROFILAXIS OF TUBERCULOSIS. |
RU2447419C2 (en) * | 2010-07-15 | 2012-04-10 | Учреждение Российской академии медицинских наук Научный центр клинической и экспериментальной медицины Сибирского отделения РАМН (НЦКЭМ СО РАМН) | METHOD FOR in vitro RECOVERY OF EXPERIMENTAL TUBERCULOUS GRANULOMA IN CULTURES |
RU2726106C1 (en) * | 2019-07-18 | 2020-07-09 | федеральное государственное бюджетное учреждение "Научно-исследовательский институт гриппа имени А.А. Смородинцева" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ гриппа им. А.А. Смородинцева" Минздрава России) | Recombinant strain of influenza virus a/pr8-ns124-tb10_4-2a-hspx and method for specific prevention of pulmonary tuberculosis using mucosal vaccine based thereon |
-
2005
- 2005-09-16 RU RU2005129049/13A patent/RU2318872C2/en active IP Right Revival
Also Published As
Publication number | Publication date |
---|---|
RU2318872C2 (en) | 2008-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Valkenburg et al. | IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection | |
MXPA02005639A (en) | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions. | |
Huang et al. | Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses | |
CN101745104B (en) | Tuberculosis subunit vaccine containing compound adjuvant | |
WO2008039267A3 (en) | Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions | |
MX2011011186A (en) | A tuberculosis tb vaccine to prevent reactivation. | |
CN100999550A (en) | Tubercle branch bacillus fusion protein and application thereof | |
CN103386128B (en) | Tuberculosis subunit vaccine containing unite adjuvant | |
Rodriguez-Carreno et al. | Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein | |
EA201171032A1 (en) | TREATMENT SCHEMES WITH THE HELP OF VACCINE AGAINST FLU, ASSOCIATED WITH PANDEMIC STRAINS | |
BRPI0816134A2 (en) | Herpesvirus, DNA sequence, vector, cell, virus, method for producing infectious particles, infectious particles, vaccine, use of herpesvirus or DNA sequence or vector or infectious particles, and method for preventive and / or treatment. treatment of a disease. | |
CN107217026A (en) | A kind of recombinant mycobacterium smegmatis strain of knockout c di AMP catabolic enzymes and its application | |
MX2010002866A (en) | Attenuated mycoplasma gallisepticum strains. | |
EP1914299A3 (en) | Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti | |
IL182440A0 (en) | Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection | |
DK1471936T3 (en) | HIV Vaccine and Method of Use | |
RU2005129049A (en) | RECOMBINANT STRAINS OF INFLUENZA VIRUS EXPRESSING MYCOBACTERIAL PROTECTIVE ANTIGEN ESAT-6, AND THEIR USE FOR PREVENTION AND TREATMENT OF TUBERCULOSIS | |
CN1674935A (en) | Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition | |
Kyei-Barffour et al. | Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative | |
MX344544B (en) | Blood stage malaria vaccine. | |
Nadolinskaia et al. | Vaccines against tuberculosis: Problems and prospects | |
CN105567660A (en) | Escherichia coli recombinate expression method of mycobacterium tuberculosis Rv 2837c active protein and applications thereof | |
Martin et al. | DNA encoding a single mycobacterial antigen protects against leprosy infection | |
Lu et al. | Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy | |
McElhaney | Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20100917 |
|
NF4A | Reinstatement of patent |
Effective date: 20120420 |